Session 3: Hot Topics 1

New Devices and Emerging Therapies

Moderators: Gerhard Scheuch (Activaero, Gemunden, Germany) and Rajiv Dhand (University of Tennessee)

Performance Testing of a Novel Continuous Powder Aerosolizer (CPA) for Inhalative Administration of Surfactant to Preterm Neonates

O Helwich1, W Koch1, P Iwatschenko2, H Windt1, FJH Taut3, C De Muynck4, and G Pohlmann1

1Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Hannover, Germany
2MTF MediTech Franken GmbH, Eckental, Germany
3Takeda Pharmaceuticals Int’l, Zürich, Switzerland
4Nycomed: a Takeda Company, Konstanz, Germany

Feasibility Testing of Low Molecular Weight Heparin (LMWH): Loaded Large Porous PEG-PLGA Microparticles for the Treatment of Asthma

B Patel, N Gupta and F Ahsan

Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, TX, United States of America

Bioengineering of siRNA for Treatment of Inflammatory Lung Disease

JM Ramsey1, C Kelly2, AB Yadav1, NG McElvaney4, D Small3, C Taggart3, and SA Cryan1

1 School of Pharmacy, Royal College of Surgeons in Ireland, Dublin 2, Ireland
School of Biology and Environment Science, University College Dublin, Dublin 4, Ireland
Centre for Infection and Immunity, Queen’s University Belfast, Belfast, United Kingdom
Respiratory Research Division, RCSI, Education and Research Centre, Beaumont Hospital, Dublin 9, Ireland

Efficacy of Inhaled Liposome-Encapsulated Ciprofloxacin against Yersinia Pestis

KA Hamblin1, JD Blanchard2, C Davies1, SV Harding1, and AJH Simpson1

1 Defence Science and Technology Laboratory, Porton Down, Salisbury, Wiltshire, United Kingdom
Aradigm Corporation, Hayward, CA, United States of America